Fig. 4.
Fig. 4. Deletion of 1B2+ CD8+ cells after transplantation in both DST-treated and non-DST–treated mice. The spleens (left panel) and lymph nodes (right panel) from naive (▪), DST-treated (□), and non-DST–treated (□) 2CF1mice 120 days after transplantation were collected and the percentages of 1B2+ CD8+ cells were compared. The percentages of 1B2+ CD8+ cells in both DST-treated and non-DST–treated mice were significantly reduced compared with that in the naive mice (*P < .001).

Deletion of 1B2+ CD8+ cells after transplantation in both DST-treated and non-DST–treated mice. The spleens (left panel) and lymph nodes (right panel) from naive (▪), DST-treated (□), and non-DST–treated (□) 2CF1mice 120 days after transplantation were collected and the percentages of 1B2+ CD8+ cells were compared. The percentages of 1B2+ CD8+ cells in both DST-treated and non-DST–treated mice were significantly reduced compared with that in the naive mice (*P < .001).

Close Modal

or Create an Account

Close Modal
Close Modal